These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 9268190)
21. Regulation of local tissue-type plasminogen activator release by endothelium-dependent and endothelium-independent agonists in human vasculature. Stein CM; Brown N; Vaughan DE; Lang CC; Wood AJ J Am Coll Cardiol; 1998 Jul; 32(1):117-22. PubMed ID: 9669258 [TBL] [Abstract][Full Text] [Related]
23. Direct vascular effects of protease-activated receptor type 1 agonism in vivo in humans. Gudmundsdóttir IJ; Megson IL; Kell JS; Ludlam CA; Fox KA; Webb DJ; Newby DE Circulation; 2006 Oct; 114(15):1625-32. PubMed ID: 17015787 [TBL] [Abstract][Full Text] [Related]
24. Plasma levels of von Willebrand factor and plasminogen activator in patients with arterial thromboembolism--with special reference to their correlation to the increased catabolism of both fibrinogen and platelets. Matsumoto M; Uchiyama T; Kobayashi N; Maekawa T Nihon Ketsueki Gakkai Zasshi; 1989 Sep; 52(6):1105-14. PubMed ID: 2588960 [TBL] [Abstract][Full Text] [Related]
25. B1 kinin receptor does not contribute to vascular tone or tissue plasminogen activator release in the peripheral circulation of patients with heart failure. Cruden NL; Tse GH; Fox KA; Ludlam CA; Megson I; Newby DE Arterioscler Thromb Vasc Biol; 2005 Apr; 25(4):772-7. PubMed ID: 15681300 [TBL] [Abstract][Full Text] [Related]
26. Preserved tissue-type plasminogen activator release and endothelium-dependent vasodilation in postmenopausal women with NIDDM. Manhem K; Dotevall A; Wilhelmsen L; Jern S J Diabetes Complications; 2000; 14(3):127-34. PubMed ID: 10989320 [TBL] [Abstract][Full Text] [Related]
28. [Thrombomodulin, von Willebrand factor and tissue plasminogen activator in the blood plasma of obese women and men]. Rość D; Drewniak W; Kinasz-Rózycka I; Kulwas A; Michalski A Pol Merkur Lekarski; 2003 Dec; 15(90):518-20. PubMed ID: 15058251 [TBL] [Abstract][Full Text] [Related]
29. Angiotensin-converting enzyme inhibition increases human vascular tissue-type plasminogen activator release through endogenous bradykinin. Pretorius M; Rosenbaum D; Vaughan DE; Brown NJ Circulation; 2003 Feb; 107(4):579-85. PubMed ID: 12566370 [TBL] [Abstract][Full Text] [Related]
30. Intra-arterial tumor necrosis factor-alpha impairs endothelium-dependent vasodilatation and stimulates local tissue plasminogen activator release in humans. Chia S; Qadan M; Newton R; Ludlam CA; Fox KA; Newby DE Arterioscler Thromb Vasc Biol; 2003 Apr; 23(4):695-701. PubMed ID: 12692009 [TBL] [Abstract][Full Text] [Related]
31. Release of tissue-type plasminogen activator (t-PA) in the splanchnic circulation of the anaesthetised pig during high sympathetic tone. Björkman JA; Ilebekk A; Jern C Thromb Res; 2010 Mar; 125(3):e106-9. PubMed ID: 19931890 [TBL] [Abstract][Full Text] [Related]